07.06.2013
- In a leafy suburb of Frankfurt, a state-of-the-art plant churns out up to 1 million insulin pens every day in French drugmaker Sanofi's drive to keep its no. 2 spot in the $43...
24.04.2013
- Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...
05.04.2013
- The Teva-Lonza Joint Venture issued the following statement today: The potential to develop, manufacture and market affordable, efficacious and safe biosimilars remains an area of...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
20.11.2012
- With an introduction to the U.S. set for 2014, and the realization of massive potential in the emerging markets of Asia, biosimilars are set to take a sizable chunk of the global...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
06.06.2012
- Germany's Merck KGaA and India's Dr. Reddy's Laboratories have struck a deal to develop cheap versions of biotech cancer drugs, seeking to tap into a new market as patents on...
13.04.2012
- Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...
